We are excited to announce the Scientific Committee for the 2019 ISV Annual Congress (www.ISVCongress.org).
Dear TRANSVAC Stakeholders,
We would like to invite you to a webinar “Structural vaccinology approach: the exploitation of the structure knowledge for the rational vaccine design/optimization " presented by prof. Lucia Banci, who is representingINSTRUCT ERIC.
NEW deadline: Immunoactive carbohydrates and adjuvants: antibacterial vaccines, from research to clinical trials
2-4 April 2019, Siena, Italy, organised by University of Florence
We have a limited number of places left on the next ENOVA Training School on “Immunoactive carbohydrates and adjuvants: antibacterial vaccines from research to clinical trials” in Sienna which is running from the 2nd to 4th April. The deadline for applications has been extended to March 8th.
The Training School is suitable for Ph.D. students and researchers who have a basic knowledge of analytical and organic chemistry and would like to increase their knowledge of vaccine development specifically in the area carbohydrate-based vaccines.
The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on “In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals.
The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on
“In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals.
This workshop is aimed to present the following topics:
1) Kinetics of vaccines distribution and persistence,
2) Pathogen penetration and dissemination,
3) Host response to vaccines and pathogens exposure.
The course provides an overview of state-of-the-art adjuvant systems and addresses the preclinical and clinical development of adjuvanted vaccines. It combines interactive theoretical parts (lectures and discussion rounds) with practical parts where participants work on different thematic case studies. Invited trainers will present the various adjuvant systems, such as Aluminum salts, Oil-in-Water emulsions, Water-in-Oil emulsions, Liposomes, PLGA particles, Virosomes, QS21, TLR ligands, as well as aspects of preclinical and clinical development of adjuvanted vaccines.For the practical parts, participants will be split into smaller groups. Each group will work on one case study, facilitated by a trainer. The trainer will introduce the case study, provide background information, and explain the tasks and questions for the group work. Following this introduction, each group will work independently on their case study for a given time and will prepare a summary of the case that will be presented to all participants at the end.
The report fromthe 2nd ENOVA Adjuvant Workshop is now available:
IDMIT, for “Infectious Disease Models and Innovative Therapies” is a national Research and Technological infrastructure for biology and health dedicated to preclinical research on infectious diseases. IDMIT is located in the CEA site of Fontenay-aux-Roses, France.
More information here
List of candidates for STSM in 2018